GENE BY GENE, LIMITED

GENE BY GENE, LIMITED specializes in high-throughput genomic sequencing and analysis of purified human DNA samples, delivering precise molecular data for research and public health applications. Their core technical expertise lies in next-generation sequencing (NGS) workflows, including library preparation, nucleic acid quantification, and bioinformatic processing of genomic data. The contractor demonstrates focused proficiency in human genomics, with experience in sample integrity management, sequence quality control, and data output tailored for scientific and clinical interpretation. Their differentiation stems from targeted execution in controlled, compliance-sensitive environments, ensuring reproducible results for federally funded research initiatives. The contractor has delivered services under the Department of Health and Human Services, specifically supporting genomic research initiatives requiring accurate DNA sequencing of human samples. This engagement reflects a specialized relationship centered on laboratory-based genomic data generation, likely supporting public health surveillance, population studies, or biomedical research programs under HHS umbrella agencies such as NIH or CDC. The nature of the work suggests a contractor embedded within scientific workflows, providing critical sequencing infrastructure rather than broad analytical or policy services. The primary NAICS classification of 541720—Research and Development in the Social Sciences and Humanities—appears misaligned with the actual technical work performed, which is squarely in the domain of molecular biology and genomics. The more accurate classification would be 541714 (Research and Development in Biotechnology), indicating a potential misclassification in federal contracting records. Despite this, the contractor’s market positioning is clearly in the biotech research services sector, serving government-funded projects requiring high-accuracy human genome sequencing. GENE BY GENE, LIMITED is a small business structured as an 8H entity, headquartered in Houston, Texas. While no formal government certifications are listed, their demonstrated capability in handling human genomic samples under federal contracts indicates adherence to laboratory standards such as CLIA or ISO 17025. Their geographic presence supports regional access to federal research hubs, positioning them as a specialized service provider within the national bioresearch ecosystem.